Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancer
CHICAGO — The use of androgen deprivation therapy (ADT) in conjunction with radiotherapy, as well as its prolonged use in the adjuvant setting, improved metastasis-free survival (MFS) and overall survival (OS) in patients with localized prostate cancer, a meta-analysis found. Adding ADT to radiotherapy significantly improved 12-year rates of MFS, the primary endpoint (HR 0.83, […]